blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3589291

EP3589291 - COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC PROTEINS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  29.06.2023
Database last updated on 16.07.2024
FormerRequest for examination was made
Status updated on  06.12.2019
FormerThe international publication has been made
Status updated on  11.09.2018
Most recent event   Tooltip27.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Vor Biopharma, Inc.
501 Boylston Street
Suite 6102
Boston, MA 02116 / US
[2020/02]
Inventor(s)01 / BOLEN, Joseph
501 Boylston Street
Suite 6102
Boston, MA 02116 / US
02 / RADOVIC-MORENO, Aleksandar, Filip
501 Boylston Street
Suite 6102
Boston, MA 02116 / US
03 / LYDEARD, John
501 Boylston Street
Suite 6102
Boston, MA 02116 / US
 [2020/02]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2020/02]
Application number, filing date18760400.428.02.2018
[2020/02]
WO2018US20327
Priority number, dateUS201762464975P28.02.2017         Original published format: US 201762464975 P
[2020/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018160768
Date:07.09.2018
Language:EN
[2018/36]
Type: A1 Application with search report 
No.:EP3589291
Date:08.01.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 07.09.2018 takes the place of the publication of the European patent application.
[2020/02]
Search report(s)International search report - published on:US07.09.2018
(Supplementary) European search report - dispatched on:EP28.10.2020
ClassificationIPC:A61K35/12, A61K35/14, A61K35/17, A61K35/38, C07K14/705, C07K16/28, C12N5/078, C12N5/0789, A61P35/02
[2020/48]
CPC:
C07K14/70596 (EP); A61K35/28 (EP,KR,US); A61K35/17 (US);
A61K38/177 (KR); A61K39/39558 (KR); A61K39/4611 (EP,KR);
A61K39/4631 (EP,KR); A61K39/464412 (EP,KR); A61K39/464429 (EP,KR);
A61K47/6817 (KR); A61K47/6867 (KR); A61P35/02 (EP,KR);
C07K14/705 (EP); C07K14/70503 (EP,US); C07K14/7051 (US);
C07K14/70517 (US); C07K14/70521 (US); C07K16/28 (KR);
C07K16/2803 (EP,KR); C07K16/3061 (EP,KR); C12N5/0634 (EP,KR);
C12N5/0647 (KR); A61K2039/505 (KR); A61K2239/38 (EP,KR);
A61K2239/48 (EP,KR); A61K2300/00 (KR); C07K2317/34 (EP,KR);
C07K2317/622 (EP,KR); C07K2317/73 (KR); C07K2319/03 (EP,KR);
C07K2319/33 (EP,KR); C12N2510/00 (KR) (-)
C-Set:
A61K39/464412, A61K2300/00 (KR,EP);
A61K39/464429, A61K2300/00 (KR,EP)
Former IPC [2020/02]A61K35/12, A61K35/14, A61K35/17, A61K35/38, C07K14/705, C07K16/28, C12N5/078, C12N5/0789
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/02]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HEMMUNG VON ZELLLINIENSPEZIFISCHEN PROTEINEN[2020/02]
English:COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC PROTEINS[2020/02]
French:COMPOSITIONS ET MÉTHODES D'INHIBITION DE PROTÉINES SPÉCIFIQUES D'UNE LIGNÉE[2020/02]
Entry into regional phase25.09.2019National basic fee paid 
25.09.2019Search fee paid 
25.09.2019Designation fee(s) paid 
25.09.2019Examination fee paid 
Examination procedure25.09.2019Examination requested  [2020/02]
26.05.2021Amendment by applicant (claims and/or description)
28.06.2023Despatch of a communication from the examining division (Time limit: M06)
08.01.2024Reply to a communication from the examining division
Fees paidRenewal fee
27.02.2020Renewal fee patent year 03
25.02.2021Renewal fee patent year 04
25.02.2022Renewal fee patent year 05
27.02.2023Renewal fee patent year 06
27.02.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP3025719  (MILTENYI BIOTEC GMBH [DE]) [X] 1-15 * paragraphs [0070] , [0072] * * pages 16-22 * * pages 27-33 *;
 [XP]WO2017066760  (UNIV COLUMBIA [US], et al) [XP] 1-15 * page 62 - page 72; claim - *;
 [XP]WO2017079400  (UNIV PENNSYLVANIA [US]) [XP] 1-15* page 38; examples 1-4 *;
 [X]  - MIRIAM Y. KIM ET AL, "273. Genome Editing Using CRISPR-Cas9 to Increase the Therapeutic Index of Antigen-Specific Immunotherapy in Acute Myeloid Leukemia", MOLECULAR THERAPY, US, (20160501), vol. 24, doi:10.1016/S1525-0016(16)33082-9, ISSN 1525-0016, page S108, XP055376172 [X] 1-5,8,10-14 * abstract *

DOI:   http://dx.doi.org/10.1016/S1525-0016(16)33082-9
International search[A]WO2011048350  (TRISTEM TRADING CYPRUS LTD [CY], et al) [A] 1-6, 7/1-6 * ; page 3, lines 14-15, page 4, lines 1-5, page 33, lines 6-14 *;
 [A]US2015283255  (MCDONAGH CHARLOTTE [US], et al) [A] 1-6, 7/1-6 * ; paragraphs [0008]-[0010], [0536] *;
 [A]WO2016176651  (HUTCHINSON FRED CANCER RES [US]) [A] 49-50, 51/49-50 * ; paragraphs [0051], [0082], [0285], [0286], [0290] *;
 [PX]WO2017066760  (UNIV COLUMBIA [US], et al) [PX] 1* ; entire document *;
 [X]  - BRINKMAN-VAN DER LINDEN, ECM et al., "CD 33/Siglec-3 Binding Specificity, Expression Pattern, and Consequences of Gene Deletion in Mice", Molecular and Cellular Biology, (20030600), vol. 23, no. 12, pages 4199 - 4206, XP055539925 [X] 37-38, 39/37-38, 56-57, 58/56-57 * ; page 4200, 2nd column, 4th paragraph, page 4201, 1st column, 1st paragraph, page 4203, 1st column, 2nd paragraph - 2nd column, 3rd paragraph; DOI: 10.1128/MCB.23.12.4199-4206.2003 *

DOI:   http://dx.doi.org/10.1128/MCB.23.12.4199-4206.2003
 [A]  - ZHAO, Y et al., "Extrathymic Generation of Tumor-Specific T Cell from Genetically Engineered Human Hematopoietic Stem Cells via Notch Signaling", Cancer Research, (20070315), vol. 67, no. 6, pages 2425 - 2429, XP055539925 [A] 49-50, 51/49-50 * ; page 2425, 1st column, 4th - 5th paragraphs; DOI: 10.1158/0008-5472.CAN-06-3977 *

DOI:   http://dx.doi.org/10.1128/MCB.23.12.4199-4206.2003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.